These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35732578)

  • 1. Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity.
    Lehman SL; Wechsler T; Schwartz K; Brown LE; Porco JA; Devine WG; Pelletier J; Shankavaram UT; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2022 Sep; 21(9):1406-1414. PubMed ID: 35732578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells.
    Hayman TJ; Wahba A; Rath BH; Bae H; Kramp T; Shankavaram UT; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2014 Jan; 20(1):110-9. PubMed ID: 24198241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo.
    Degorre C; Lohard S; Bobrek CN; Rawal KN; Kuhn S; Tofilon PJ
    Sci Rep; 2024 Jul; 14(1):17316. PubMed ID: 39068290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Wahba A; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Aug; 17(8):1717-1726. PubMed ID: 29866745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation initiation factor eIF4E is a target for tumor cell radiosensitization.
    Hayman TJ; Williams ES; Jamal M; Shankavaram UT; Camphausen K; Tofilon PJ
    Cancer Res; 2012 May; 72(9):2362-72. PubMed ID: 22397984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization.
    Lehman SL; Wilson ED; Camphausen K; Tofilon PJ
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
    Rath BH; Waung I; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
    Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
    Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity.
    Hayman TJ; Kramp T; Kahn J; Jamal M; Camphausen K; Tofilon PJ
    Transl Oncol; 2013 Jun; 6(3):355-62. PubMed ID: 23730416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
    Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM
    Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.
    Leiker AJ; DeGraff W; Choudhuri R; Sowers AL; Thetford A; Cook JA; Van Waes C; Mitchell JB
    Clin Cancer Res; 2015 Jun; 21(12):2792-801. PubMed ID: 25724523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
    Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ
    Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
    Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
    Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
    Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
    Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone).
    Barker CA; Burgan WE; Carter DJ; Cerna D; Gius D; Hollingshead MG; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2006 May; 12(9):2912-8. PubMed ID: 16675588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
    Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
    Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.